The health benefits of OPC are numerous and significant. Masquelier'sª OPC has been proven clinically effective throughout nearly 50 years of research and worldwide use.
It is well documented that Primary Source OPC can benefit a number of different systems and body parts - several studies are shown here. For more information, contact us.
Studies:
Here are selected studies, click to see a summary of results.
Study 1 - Inhibition Of Angiotensin I Converting Enzyme By Flavanolic Compounds: In-Vitro and In-Vivo Studies
Study 2 - Action Des Oligomeres Procyanidoliques Sur Le Cobaye Carence En Vitamine C (Effect Of Procyanidolic Oligomers On The Guinea Pig Deprived Of Vitamin C.)
Study 3 - Action Comparee De Divers Facteurs Vitaminiques P Sur L'oxydation De L'acide Ascorbique Par Les Ions Cuivriques. (Comparative Action Of Various Vitamin P Related Factors On The Oxidation Of Ascorbic Acid By Cupric Ions)
Study 4 - Action Comparee De Divers Facteurs Vitaminques P Sur L'acide Ascorbique-Oxidase (Comparative Action Of Various Vitamin P Related Factors On Ascorbic Acid Oxidase)
Study 5 - Oedema Inhibiting Effect Of Procyanidin
Study 6 - Action Du Leucocyanidol Sur L'hyaluronidase (Action Of Leucocyanidol On Hyaluronidase)
Study 7 - Action Protectrice Du Vin Sur L'ulcere Gastrique (Protective Action Of Wine Against Gastric Ulcers)
Study 8 - Inhibitory Effects Of Tannins On Hyaluronidase Activation and On The Degranulation From Rat Mesentery Mast Cells
Study 9 - Histamine And Acute Haemorrhagic Lesions In Rat Gastric Mucosa: Prevention Of Stress Ulcer Formation By +(-) Catechin, And Inhibitor Of Specific Histidine Decarboxylase In Vitro
Study 10 - Activite Angioprotectrice Des Oligomeres Procyanidoliques Chez L'animal/Oedeme De La Patte (Angioprotective Activity Of Oligomeric Proanthocyanidins In Animals/Paw Oedema)
Study 11 - Activite Angioprotectrice Des Oligomeres Procyanidoliques Chez L'animal/Activite Antiagoniste Vis-A-Vis Des Mediateurs De L'inflamation (Angioprotective Activity Of Oligomeric Proanthocyanidins In Animals/Antagonistic Activity Against Inflammatory Mediators)